The public registers hold a second record for MSN Life Sciences. The fuller profile, with 517 active US DMFs and 121 valid CEPs, is at MSN Laboratories. Figures on this page cover only this record.
MSN Life Sciences is an API and finished-dose manufacturer based in India. It holds 160 active US drug master files and 48 valid CEPs. Its filings concentrate with ARCSA (EC), CDSCO (India) and MINSA (CR). Its GMP standing is certified by EMA, MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 13 September 2024 as VAI. Customs aggregates show $9.6M of exports covering 198 molecules to 34 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chandampet Village, India | Not on file |
| Medak District, India | 3011543392 |
| Bhiknoor Village, India | Not on file |
| Medak, India | Not on file |
| Kamareddy, India | Not on file |
| Kamareddy District, India | 3014775167 |
| Molecule | Regulators | Docs |
|---|---|---|
| Esomeprazole | EDQM, SFDA (Saudi Arabia), US FDA | 7 |
| Sacubitril | SFDA (Saudi Arabia), US FDA | 6 |
| Sitagliptin | EDQM, SFDA (Saudi Arabia), US FDA | 5 |
| Apremilast | US FDA | 4 |
| Macitentan | SFDA (Saudi Arabia), US FDA | 4 |
| Mebendazole | EDQM, US FDA | 4 |
| Metoprolol | EDQM, US FDA | 4 |
| Pirfenidone | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Riociguat | EDQM, SFDA (Saudi Arabia), US FDA | 4 |
| Darunavir | SFDA (Saudi Arabia), US FDA | 3 |
| Empagliflozin | SFDA (Saudi Arabia), US FDA | 3 |
| Haloperidol | EDQM, US FDA | 3 |
| Levetiracetam | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Losartan | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Albendazole | EDQM, US FDA | 2 |
| Atorvastatin | SFDA (Saudi Arabia), US FDA | 2 |
| Bupivacaine | EDQM, US FDA | 2 |
| Canagliflozin | US FDA | 2 |
| Caspofungin | SFDA (Saudi Arabia), US FDA | 2 |
| Clobazam | EDQM, US FDA | 2 |
| Clopidogrel | US FDA | 2 |
| Desvenlafaxine | US FDA | 2 |
| Dolutegravir | US FDA | 2 |
| Doxepin | EDQM, US FDA | 2 |
| Elvitegravir | US FDA | 2 |
| Famotidine | EDQM, US FDA | 2 |
| Flecainide | EDQM, US FDA | 2 |
| Fluphenazine | US FDA | 2 |
| Gadobutrol | EDQM, US FDA | 2 |
| Glimepiride | EDQM, US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 45 | None |
| CDSCO (India) | 22 | None |
| MINSA (CR) | 9 | None |
| INVIMA (CO) | 8 | None |
| EMA | None | 2 |
| MFDS (Korea) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $8.0M | 30 |
| 2025 | Not reported | $9.6M | 34 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. MSN Life Sciences comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.